⚠ For informational purposes only — not a substitute for professional medical advice. Emergencies: 911 or Poison Control 1-800-222-1222.
Benzodiazepine Head-to-Head · Schedule IV
Xanax
alprazolam
VS
Klonopin
clonazepam

Both are DEA Schedule IV benzodiazepines that enhance GABA-A receptor activity — but they're clinically quite different drugs. The key dividing line is half-life: Xanax is short-acting, Klonopin is long-acting. That single difference cascades into distinct onset profiles, rebound patterns, approved indications, and withdrawal characteristics.

How both drugs work: Alprazolam and clonazepam are positive allosteric modulators of the GABA-A receptor. They bind to a site on the receptor distinct from where GABA itself binds, increasing the frequency of chloride channel opening when GABA is present. This enhances inhibitory neurotransmission throughout the central nervous system, producing sedation, anxiolysis, muscle relaxation, and anticonvulsant effects. Neither drug creates GABA — they amplify its signal.

DEA Schedule IV Both Rx-only Both generic available GABA-A modulators

Half-Life: Short vs Long

Half-life determines how long the drug stays active in the body — and drives almost every clinical difference between these two medications.

Half-life varies by individual factors including age, liver function, and body composition. These are population-level estimates.

At a Glance

Edge badges mark where one drug has a meaningful clinical advantage for a given property.

Property Xanax (alprazolam) Klonopin (clonazepam)
DEA Schedule Schedule IV Schedule IV
Drug class Benzodiazepine Benzodiazepine
Mechanism GABA-A positive allosteric modulator GABA-A positive allosteric modulator
Half-life 6–12 hours — short-acting 18–50 hours — long-acting longer
Onset of action ~30–60 min faster ~1–4 hours
FDA-approved uses
  • Anxiety disorders
  • Panic disorder
  • Panic disorder
  • Seizure disorders
  • Lennox-Gastaut syndrome
  • Akinetic epilepsy
  • Myoclonic epilepsy
Available strengths 0.25mg, 0.5mg, 1mg, 2mg tablets
also extended-release (XR)
0.5mg, 1mg, 2mg tablets
also orally disintegrating wafers
Generic available Yes — widely Yes — widely
Rebound anxiety risk Higher — interdose rebound common Lower — stable levels between doses
Withdrawal severity More abrupt — rapid clearance Smoother — gradual natural taper gentler
Misuse potential Higher — faster onset/offset cycle High — all benzodiazepines carry risk
Seizure treatment Not approved FDA-approved only option
Long-term use Both are NOT recommended for long-term use per current guidelines — dependence risk is significant for either drug

All benzodiazepines require a prescription. Treatment decisions — including which drug, strength, and duration — belong to your prescriber.

Each Drug in Depth

The colored bar at the top of each card matches the drug's identity color used throughout this page.

Alprazolam Xanax · Xanax XR · Niravam
Half-Life 6–12 hours
Anxiety Disorders Panic Disorder Short-Acting

Alprazolam is among the most frequently prescribed benzodiazepines in the United States and is the drug most people mean when they say "Xanax." Its defining characteristic is a short half-life — typically 6 to 12 hours — which gives it a faster, more noticeable onset than longer-acting benzodiazepines but also means it clears the system relatively quickly.

This pharmacokinetic profile has direct clinical consequences. The faster onset makes alprazolam feel more immediately effective for acute anxiety, which is one reason it is commonly used and commonly misused — the rapid relief is perceptible. The rapid clearance, however, is what produces interdose rebound: as levels fall between doses, some patients experience a return of anxiety that can feel worse than before they took the medication. This rebound cycle can reinforce reliance on the drug.

Alprazolam's FDA approvals cover anxiety disorders and panic disorder. It is not approved for seizure management. Extended-release tablets (Xanax XR) were developed to smooth out the peak-and-trough fluctuations of the immediate-release form, though the underlying half-life of the drug itself doesn't change.

Withdrawal note

Because alprazolam clears quickly, abrupt discontinuation can trigger withdrawal within hours. Symptoms can be severe and in some cases medically serious. Never stop without a prescriber-supervised taper plan — the rapid clearance makes this more urgent than with longer-acting benzodiazepines.

Clonazepam Klonopin
Half-Life 18–50 hours
Panic Disorder Seizure Disorders Long-Acting

Clonazepam occupies a distinct position among benzodiazepines: it is one of the few in its class with FDA approval for seizure disorders, and its long half-life of 18 to 50 hours makes it pharmacokinetically quite different from short-acting agents like alprazolam. Blood levels remain relatively steady between doses, which has practical benefits for both mood stability and the eventual process of stopping the drug.

The slower onset — typically 1 to 4 hours — means clonazepam is less well-suited for as-needed relief of an acute panic attack in progress, but better suited to providing consistent background anxiolysis throughout the day. For patients whose anxiety is persistent rather than episodic, many prescribers prefer clonazepam precisely because it does not create the rebound cycle that shorter-acting agents do.

Clonazepam is FDA-approved for panic disorder and several seizure disorders, including Lennox-Gastaut syndrome, akinetic epilepsy, and myoclonic epilepsy. This anticonvulsant indication is something alprazolam cannot fill — it is a clinically meaningful distinction between the two drugs, not just a labeling difference.

On stopping: Clonazepam's long half-life provides a partial built-in buffer when the drug is tapered — blood levels fall slowly, giving the CNS time to adapt. This makes the taper process somewhat more manageable than with alprazolam, though it still must be done gradually under prescriber supervision. Clonazepam is sometimes deliberately used as a transition drug when tapering patients off shorter-acting benzodiazepines.

Which Drug for Which Situation?

These are general clinical tendencies, not prescribing recommendations. Your prescriber considers your full history, other medications, and specific diagnosis.

Acute panic attack (in-the-moment)
Xanax edge
Faster onset means quicker symptom relief. Better suited to as-needed rescue use when a panic attack is already occurring.
Seizure disorder
Klonopin only
Clonazepam has FDA approval for epilepsy and specific seizure syndromes. Alprazolam does not and is not used for this purpose.
Long-term anxiety management
Klonopin preferred
Stable blood levels reduce the rebound anxiety cycle. Many prescribers reach for clonazepam when longer-term use is anticipated, though both carry significant dependence risk.
Minimizing rebound anxiety
Klonopin edge
Long half-life means drug levels don't drop steeply between doses. Patients on clonazepam are less likely to experience interdose anxiety spikes.
Tapering / planned discontinuation
Klonopin smoother
Slow clearance provides a gentler natural taper. Some clinicians switch patients from alprazolam to clonazepam specifically to facilitate a safer taper.
Minimizing misuse risk
Neither — both high risk
Both are Schedule IV with significant dependence and misuse potential. Alprazolam's faster onset/offset cycle makes it more commonly misused, but clonazepam is not safe in this respect.
→
All Benzodiazepines Compared
→
Anxiety Medications Guide
→
Alprazolam Drug Profile
→
Clonazepam Drug Profile

Common Questions

Is Xanax or Klonopin stronger?
Potency comparisons between benzodiazepines are nuanced and depend on what you mean by "stronger." Clonazepam (Klonopin) is considered more potent by weight — meaning a smaller amount produces a comparable effect to a larger amount of alprazolam (Xanax). However, this doesn't make one universally "stronger" in clinical terms. Xanax's faster onset and shorter half-life create a more intense but brief effect, while Klonopin's longer duration produces a steadier, more sustained level of sedation and anxiolysis. Your prescriber selects based on your diagnosis and clinical picture, not on a simple potency ranking.
Which is better for panic attacks, Xanax or Klonopin?
For acute, in-the-moment panic attacks, alprazolam (Xanax) has a practical advantage: its faster onset (typically 30–60 minutes versus Klonopin's 1–4 hours) means it can begin relieving symptoms sooner. However, "better" depends on the full clinical picture. For someone with frequent panic attacks, Klonopin's longer half-life provides more consistent background coverage, potentially reducing how often attacks occur in the first place and reducing the need for as-needed rescue use. Both are FDA-approved for panic disorder. Your prescriber will consider your attack frequency, history, and overall treatment plan.
Why does Xanax cause more rebound anxiety than Klonopin?
This comes down directly to half-life. Alprazolam (Xanax) has a short half-life of approximately 6–12 hours. As each dose wears off, blood levels drop rapidly — and the brain, which has partially adapted to the drug's presence, experiences a relative gap before the next dose. This gap often manifests as heightened anxiety, restlessness, or irritability between doses, a phenomenon called interdose rebound anxiety. Clonazepam (Klonopin), with its 18–50 hour half-life, clears the system far more slowly. Blood levels remain relatively stable between doses, which means the brain experiences much less of the on/off cycling that drives rebound. The drug's pharmacokinetics, not its potency, are what determine this difference.
Which is safer to stop taking, Xanax or Klonopin?
Neither should ever be stopped abruptly — benzodiazepine withdrawal can be medically serious, and in severe cases life-threatening. Both require prescriber-supervised tapering in every case. That said, clonazepam (Klonopin) is generally associated with a smoother withdrawal process. Its long half-life means blood levels decline gradually when the drug is tapered, giving the nervous system time to readjust incrementally. Alprazolam (Xanax) clears much faster; stopping it abruptly can trigger a rapid, more intense withdrawal that can be difficult to manage. This is one reason clinicians sometimes deliberately switch patients from alprazolam to a longer-acting benzodiazepine like clonazepam or diazepam as part of a structured taper protocol. Never stop either medication without a prescriber-guided taper plan.
Can you take Xanax and Klonopin together?
Combining alprazolam and clonazepam is not standard practice and carries real risks. Both work through the same mechanism — potentiating GABA-A receptor activity — and taking two benzodiazepines simultaneously compounds CNS depression, respiratory depression, and cognitive impairment without providing meaningful added benefit over a well-chosen single agent. Concurrent use also increases dependence risk and complicates any future taper. There are narrow clinical scenarios where a prescriber might briefly use one agent while transitioning from another, but this is closely supervised and time-limited. Do not combine these medications without explicit direction from your prescriber.
Important notice

This page is designed for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Alprazolam (Xanax) and clonazepam (Klonopin) are controlled substances and must only be prescribed, started, adjusted, or stopped under the supervision of a qualified prescriber who knows your complete medical history, current medications, and circumstances. Benzodiazepine dependence and withdrawal can be medically serious — never adjust your use without prescriber guidance. If you are experiencing a medical emergency, call 911. For questions about your medications, contact your prescriber or pharmacist. Poison Control: 1-800-222-1222.